Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Angiogenic and Stromal Remodeling Associated With Aggressive Fibrosarcomatous Dermatofibrosarcoma Protuberans. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2020 · External reference
Deregulation of the Platelet‐Derived Growth Factor B‐Chain Gene via Fusion With Collagen Gene COL1A1 in Dermatofibrosarcoma Protuberans and Giant‐Cell Fibroblastoma
10.1038/ng0197-95 · 1997 · External reference
Genetics of Dermatofibrosarcoma Protuberans Family of Tumors: From Ring Chromosomes to Tyrosine Kinase Inhibitor Treatment
10.1002/gcc.10202 · 2003 · External reference
Detection of COL1A1‐PDGFB Fusion Transcripts and PDGFB/PDGFRB mRNA Expression in Dermatofibrosarcoma Protuberans
10.1038/modpathol.3800783 · 2007 · External reference
Dermatofibrosarcoma Protuberans COL1A1‐PDGFB Fusion Is Identified in Virtually All Dermatofibrosarcoma Protuberans Cases When Investigated by Newly Developed Multiplex Reverse Transcription Polymerase Chain Reaction and Fluorescence in Situ Hybridization Assays
10.1016/j.humpath.2007.06.009 · 2008 · External reference
Current Update on the Molecular Biology of Cutaneous Sarcoma: Dermatofibrosarcoma Protuberans
10.1007/s11864-019-0628-3 · 2019 · External reference
Fibrosarcomatous (“High‐Grade”) Dermatofibrosarcoma Protuberans: Clinicopathologic and Immunohistochemical Study of a Series of 41 Cases With Emphasis on Prognostic Significance
10.1097/00000478-199805000-00009 · 1998 · External reference
Sarcomas Arising in Dermatofibrosarcoma Protuberans: A Reappraisal of Biologic Behavior in Eighteen Cases Treated by Wide Local Excision With Extended Clinical Follow Up
10.1097/00000478-200008000-00010 · 2000 · External reference
Dermatofibrosarcoma Protuberans: A Clinicopathologic Analysis of Patients Treated and Followed at a Single Institution
10.1002/1097-0142(20000615)88:12<2711::aid-cncr9>3.0.co;2-m · 2000 · External reference
The Prognostic Significance of Fibrosarcomatous Transformation in Dermatofibrosarcoma Protuberans
10.1097/00000478-200604000-00002 · 2006 · External reference
Hallmarks of Cancer: The Next Generation
10.1016/j.cell.2011.02.013 · 2011 · External reference
Microenvironmental Regulation of Tumor Progression and Metastasis
10.1038/nm.3394 · 2013 · External reference
Cellular and Molecular Landscape of Primary Dermatofibrosarcoma Protuberans: Insights From Single‐Cell RNA Sequencing Analysis
10.1111/exd.15121 · 2024 · External reference
Gene Expression Patterns and Gene Copy Number Changes in Dermatofibrosarcoma Protuberans
10.1016/s0002-9440(10)63593-6 · 2003 · External reference
Targeting the PDGF/PDGFR Signaling Pathway for Cancer Therapy: A Review
10.1016/j.ijbiomac.2022.01.113 · 2022 · External reference
Clinical Significance of Vascular Endothelial Growth Factor Expression and Microvessel Density in Invasive Cervical Cancer
10.2152/jmi.62.154 · 2015 · External reference
Expression and Prognostic Impact of VEGF, CD31 and alphaSMA in Resected Primary Lung Cancers
10.21873/anticanres.12695 · 2018 · External reference
QuPath: Open Source Software for Digital Pathology Image Analysis
10.1038/s41598-017-17204-5 · 2017 · External reference
Gene Set Enrichment Analysis: A Knowledge‐Based Approach for Interpreting Genome‐Wide Expression Profiles
10.1073/pnas.0506580102 · 2005 · External reference
Limma Powers Differential Expression Analyses for RNA‐Sequencing and Microarray Studies
10.1093/nar/gkv007 · 2015 · External reference
edgeR: A Bioconductor Package for Differential Expression Analysis of Digital Gene Expression Data
10.1093/bioinformatics/btp616 · 2010 · External reference
Impact of Tertiary Lymphoid Structure on Prognosis and Tumor Microenvironment in Undifferentiated Pleomorphic Sarcoma
10.1111/cas.70018 · 2025 · External reference
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab‐Based Treatment
10.3390/biomedicines11102721 · 2023 · External reference
CCL2 Expression in Tumor Cells and Tumor‐Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage
10.3390/cancers12051253 · 2020 · External reference
Estrogen Receptor Analyses. Correlation of Biochemical and Immunohistochemical Methods Using Monoclonal Antireceptor Antibodies
1985 · External reference
Characterization of Cancer‐Associated Fibroblasts (CAFs) and Development of a CAF‐Based Risk Model for Triple‐Negative Breast Cancer
10.1186/s12935-023-03152-w · 2023 · External reference
Fibroblast Activation Protein Expression by Stromal Cells and Tumor‐Associated Macrophages in Human Breast Cancer
10.1016/j.humpath.2013.06.016 · 2013 · External reference
Proteomic Analysis Identifies Association of Periostin, a Matricellular Protein, With High Tumor Stroma and Immune Exclusion in Triple‐Negative Breast Cancer
10.4143/crt.2025.145 · 2026 · External reference
The Absence of HLA Class I Expression in Non‐Small Cell Lung Cancer Correlates With the Tumor Tissue Structure and the Pattern of T Cell Infiltration
10.1002/ijc.30489 · 2017 · External reference
Tumor Angiogenesis: Review of Current Applications in Tumor Prognostication
1993 · External reference
Tumor Angiogenesis: Causes, Consequences, Challenges and Opportunities
10.1007/s00018-019-03351-7 · 2020 · External reference
VEGF as a Therapeutic Target in Cancer
10.1159/000088479 · 2005 · External reference
VEGF in Signaling and Disease: Beyond Discovery and Development
10.1016/j.cell.2019.01.021 · 2019 · External reference
CircRNA‐miRNA‐VEGFA: An Important Pathway to Regulate Cancer Pathogenesis
10.3389/fphar.2023.1049742 · 2023 · External reference
Macrophage Diversity Enhances Tumor Progression and Metastasis
10.1016/j.cell.2010.03.014 · 2010 · External reference
Role of the CCL2‐CCR2 Signalling Axis in Cancer: Mechanisms and Therapeutic Targeting
10.1111/cpr.13115 · 2021 · External reference
STC1 Competitively Binding betaPIX Enhances Melanoma Progression via YAP Nuclear Translocation and M2 Macrophage Recruitment Through the YAP/CCL2/VEGFA/AKT Feedback Loop
10.1016/j.phrs.2024.107218 · 2024 · External reference
CXCL12 (SDF‐1)/CXCR4 Pathway in Cancer
10.1158/1078-0432.ccr-09-2329 · 2010 · External reference
CXCR4/CXCL12 Axis Promotes VEGF‐Mediated Tumor Angiogenesis Through Akt Signaling Pathway
10.1016/j.bbrc.2007.05.182 · 2007 · External reference
Multiple Myeloma Cells Recruit Tumor‐Supportive Macrophages Through the CXCR4/CXCL12 Axis and Promote Their Polarization Toward the M2 Phenotype
10.18632/oncotarget.2207 · 2014 · External reference
A Framework for Advancing Our Understanding of Cancer‐Associated Fibroblasts
10.1038/s41568-019-0238-1 · 2020 · External reference
Cancer‐Associated Fibroblast‐Induced Remodeling of Tumor Microenvironment in Recurrent Bladder Cancer
2023 · External reference
The Biology and Function of Fibroblasts in Cancer
10.1038/nrc.2016.73 · 2016 · External reference
Role of Periostin in Cancer Progression and Metastasis: Inhibition of Breast Cancer Progression and Metastasis by Anti‐Periostin Antibody in a Murine Model
2011 · External reference
Periostin Blockade Overcomes Chemoresistance via Restricting the Expansion of Mesenchymal Tumor Subpopulations in Breast Cancer
10.1038/s41598-018-22340-7 · 2018 · External reference
